Dr. Michael Jain is an Associate Member and ICE-T Medical Director in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr. Jain earned his MD and PhD at McGill University in Montréal, in the province of Québec, Canada. His PhD in Cell Biology was completed under the supervision of Dr. John Bergeron. Dr Jain completed an Internal Medicine Residency and a Hematology Residency at the University of Toronto. He completed a Clinician Scientist Training Program and Clinical Fellowship in Lymphoma and Autologous Stem Cell Transplantation at Princess Margaret Cancer Center, University of Toronto. Dr. Jain’s clinical interests focus on treatment modalities for relapsed lymphoma, particularly stem cell transplantation and cellular and immunotherapies. His research interests include translational research in lymphoma and early-phase clinical trials.

Dr. Bianca Santomasso is an Assistant Attending Neuro-Oncologist at Memorial Sloan Kettering Cancer Center and an Assistant Professor of Neurology at Weill Cornell Medical College with expertise in the diagnosis and management of neurologic complications of immunotherapies including Immune effector cell therapies.

She has published and presented extensively on the topic of neurotoxicity from CAR T cell therapies and has served on several toxicity grading/management guidelines panels including for the American Society of Transplantation and Cellular Therapy (ASTCT), the National Comprehensive Cancer Network (NCCN), The American Society of Clinical Oncology (ASCO), and the Society of Immunotherapy of Cancer (SITC). She has a special research interest in understanding the mechanisms of acute and chronic neurotoxicity arising from CAR T-cell treatments in order to develop new therapeutic strategies.